Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Myriad Genetics Inc

In Vitro & In Vivo Diagnostic Substances · Salt Lake City, UT, United States

  1. PrincipalsBenjamin Richard WheelerChief Financial OfficerBrian J DonnellyChief Commerical OfficerDale MuzzeyChief Scientific Officerand 8 more
  2. CompanyMyriad Genetics IncSalt Lake City, UT, United States
  3. Phone line+1 (801) 584-3600General business
Request a quotemyriad.com ↗

Myriad Genetics Inc is an SEC-registered Nasdaq-listed company (ticker MYGN) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions

People 11

Chief executive

Samraat S. RahaPresident and CEO

Chair & board

S. Louise PhanstielDirector (Board)

Finance

Benjamin Richard WheelerChief Financial Officer
Natalie MunkChief Accounting Officer

Operations

Mark VerrattiChief Operating Officer

Technology & engineering

Kevin Richard HaasChief Technology Officer

Legal

Jennifer Lynne FoxChief Legal Officer
Everyone else on file (4)
Brian J DonnellyChief Commerical Officer
Dale MuzzeyChief Scientific Officer
Shereen SolaimanChief People Officer
Margaret AnconaEVP, Strategy & Transformation

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Dale Muzzey — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Brian J Donnelly — Chief Commerical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Jennifer Lynne Fox — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Benjamin Richard Wheeler — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers